North China Pharmaceutical Company Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 10,304.38 million compared to CNY 11,430.48 million a year ago. Revenue was CNY 10,384.58 million compared to CNY 11,492.5 million a year ago. Net income was CNY 18.73 million compared to CNY 97.32 million a year ago. Basic earnings per share from continuing operations was CNY 0.011 compared to CNY 0.06 a year ago. Diluted earnings per share from continuing operations was CNY 0.011 compared to CNY 0.06 a year ago.